Autonomic nervous system control of the cardiovascular and respiratory systems in asthma.
Patients with asthma have exaggerated bronchoconstriction of their airways in response to certain indirect (e.g. cold air, allergens, dust, exercise) or direct (e.g. inhaled methacholine) stimuli. This 'hyper-reactivity' usually co-exists with airway inflammation, although the pathophysiological mechanisms underlying these changes are not fully understood. It is likely that this hyper-reactivity is associated with abnormal autonomic nervous system (ANS) control. In particular, the parasympathetic (vagal) component of the ANS appears to be implicated in the pathogenesis of asthma. In addition, several studies have suggested the existence of differential alteration in ANS function following exercise in asthmatics compared with non-asthmatic individuals. Several early studies suggested that the altered autonomic control of airway calibre in asthma might be reflected by a parallel change in heart rate. Cardiac vagal reactivity does indeed appear to be increased in asthma, as demonstrated by the cardiac response to various autonomic functions tests. However, other studies have reported a lack of association between bronchial and cardiac vagal tone, and this is in accord with the concept of system-independent ANS control. This review provides a discussion of cardiovascular-autonomic changes associated with either the pathophysiology of asthma per se or with asthma pharmacotherapy treatment. Previous investigations are summarised suggesting an apparent association between altered autonomic-cardiovascular control and bronchial asthma. The full extent of autonomic dysfunction, and its clinical implications, has yet to be fully determined and should be the subject of future investigation.
Lewis
M J
MJ
Department of Sports Science, University of Wales Swansea, Singleton Park, Swansea SA2 8PP, UK. m.j.lewis@swansea.ac.uk
Short
A L
AL
Lewis
K E
KE
D000318:Adrenergic beta-Agonists / Q000494:pharmacology; D001249:Asthma / Q000188:drug therapy / Q000503:physiopathology*; D001342:Autonomic Nervous System Diseases / Q000503:physiopathology*; D001794:Blood Pressure / Q000502:physiology; D002320:Cardiovascular Physiological Phenomena; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D006339:Heart Rate / Q000502:physiology; D006801:Humans; D009479:Neuropeptides / Q000502:physiology; D009569:Nitric Oxide / Q000502:physiology; D012143:Respiratory Physiological Phenomena
D000318:Adrenergic beta-Agonists; D018680:Cholinergic Antagonists; D009479:Neuropeptides; D009569:Nitric Oxide